posted on 04/24/2012 3:13:28 PM PDT
[Art.] One result: As biotech and medical discoveries accelerate, the number of new drugs approved by the agency remains basically flat.
That's because they know that under Obamacare, only one drug will be needed for geriatric cases. Cyanide.
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson